Filing Details
- Accession Number:
- 0000899243-19-003848
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-15 16:31:38
- Reporting Period:
- 2019-02-13
- Accepted Time:
- 2019-02-15 16:31:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1754129 | D. Justin Gover | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2019-02-13 | 22,620 | $12.50 | 370,445 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.
- These ordinary shares are represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer. The reporting person acquired these shares on December 20, 2018 in connection with an exercise of options that were due to expire on December 24, 2018.
- The price reported in Column 4 is price per ordinary share ($150.0 per ADS).